Table 2.
Histomorphometric outcomes
| DAY 7 OUTCOMES | PEG | VitE5 | VitE25 | VitE50 |
|---|---|---|---|---|
| Cross-Sectional Area [mm 2 ] | 23.4 ± 10.0 | 32.2 ± 4.2* | 27.7 ± 4.3 | 26.6 ± 4.6 |
| % Fibrotic Area | 34.6 ± 10.4 | 28.5 ± 10.1 | 24.0 ± 6.3 | 34.5 ± 9.6 |
| Myofibers (n) | 8.16e3 ± 4.35e3 | 1.10e4 ± 1.81e3 | 8.41e3 ± 1.80e2 | 8.79e3 ± 1.51e3 |
| Median Min. Feret Diameter (µm) | 29.2 ± 2.4 | 30.1 ± 1.9 | 31.0 ± 2.0 | 30.6 ± 1.4 |
| DAY 28 OUTCOMES | PEG | VitE5 | VitE25 | VitE50 |
| Cross-Sectional Area [mm 2 ] | 38.1 ± 3.4 | 36.3 ± 6.0 | 32.7 ± 2.5 | 40.6 ± 4.2 |
| % Fibrotic Area | 21.7 ± 9.6 | 36.1 ± 14.0 | 10.1 ± 9.0 | 24.9 ± 14.9 |
| Myofibers (n) | 1.02e4 ± 1.31e3 | 9.58e3 ± 2.34e3 | 8.00e3 ± 6.07e2 | 1.11e4 ± 9.55e2 |
| Median Min. Feret Diameter (µm) | 33.7 ± 4.5 | 29.3 ± 4.0* | 35.9 ± 2.6 | 30.9 ± 5.8 |
Notes: all data are Mean ± SD *P < 0.05 relative to PEG at same timepoint